[{"arm_notes": "", "treatment_id": null, "treatment_name": "Group name:Investigational vaccine 1: Type of group;1 N\u00b0 of participants:4000 Intervention(s) description:Inactivated SARS-CoV-2 vaccine (Vero cell)\t\t\t\tManufacturer: Wuhan Institute of Biological Products Co.; Ltd.\t\t\t\tSpecification: 200WU/dose for per human use; 0.5 mL/ dose\t\t\t\tsolution for parenteral injection; intramuscular; 0.5 ml/dose; two doses (Day 0; day 21-28)\t\t\t\tGroup name:Placebo Type of group;2 N\u00b0 of participants:4000 Intervention(s) description:Product name: Placebo/Aluminum Adjuvant of Inactivated SARS-CoV-2 vaccine\t\t\t\tActive Ingredient: None; Virus Contents: None\t\t\t\tAdjuvant: aluminum hydroxide\t\t\t\tManufacturer: Wuhan Institute of Biological Products Co.; Ltd.\t\t\t\tSpecification: 0.5 mL/ dose; 0.5mL for per human use; two doses (day 0; day 21-28)\t\t\t\tSolution for parenteral injection (intramuscular)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "200WU/dose", "treatment_id": 1923, "treatment_name": "Inactivated sars-cov-2 vaccine (vero cell)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "4\u03bcg/dose", "treatment_id": 1923, "treatment_name": "Inactivated sars-cov-2 vaccine (vero cell)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]